COLOMBA, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 1.729
NA - Nord America 1.562
EU - Europa 727
SA - Sud America 324
Continente sconosciuto - Info sul continente non disponibili 146
AF - Africa 36
OC - Oceania 9
Totale 4.533
Nazione #
US - Stati Uniti d'America 1.477
SG - Singapore 678
CN - Cina 388
IT - Italia 327
BR - Brasile 248
VN - Vietnam 189
HK - Hong Kong 165
FR - Francia 103
BD - Bangladesh 95
NL - Olanda 82
GB - Regno Unito 58
DE - Germania 50
KR - Corea 46
CA - Canada 42
JP - Giappone 34
FI - Finlandia 32
IN - India 31
AR - Argentina 26
MX - Messico 18
TR - Turchia 16
PL - Polonia 15
CO - Colombia 14
EC - Ecuador 10
ID - Indonesia 10
IQ - Iraq 10
ZA - Sudafrica 10
AU - Australia 9
ES - Italia 9
SA - Arabia Saudita 9
SE - Svezia 9
PH - Filippine 8
EG - Egitto 7
JM - Giamaica 7
PY - Paraguay 7
IL - Israele 6
TN - Tunisia 6
VE - Venezuela 6
PE - Perù 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
GT - Guatemala 4
IE - Irlanda 4
LT - Lituania 4
UZ - Uzbekistan 4
AT - Austria 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
MY - Malesia 3
PK - Pakistan 3
RU - Federazione Russa 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
KW - Kuwait 2
NI - Nicaragua 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LS - Lesotho 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SZ - Regno dello Swaziland 1
Totale 4.386
Città #
Singapore 410
Santa Clara 389
San Jose 207
Hong Kong 159
Hefei 121
Ashburn 118
Beijing 78
Los Angeles 77
Lauterbourg 75
Ho Chi Minh City 63
Dallas 47
Hanoi 47
Seoul 44
Rome 30
Council Bluffs 28
Tokyo 26
Frankfurt am Main 24
New York 24
São Paulo 22
Milan 20
Naples 20
Buffalo 18
Lappeenranta 18
Palermo 16
Guangzhou 15
Helsinki 13
Atlanta 12
London 12
Orem 12
Rio de Janeiro 11
Düsseldorf 9
Charlotte 8
Chicago 8
Da Nang 8
Houston 8
Mexico City 8
Padua 8
Stockholm 8
Warsaw 8
Brasília 7
Elk Grove Village 7
Florence 7
Haiphong 7
Hyderabad 7
Toronto 7
Ankara 6
Belo Horizonte 6
Cairo 6
Chennai 6
Minamishinagawa 6
Montreal 6
Munich 6
Riyadh 6
The Bronx 6
Turin 6
Bengaluru 5
Biên Hòa 5
Bogotá 5
Bologna 5
Curitiba 5
Paris 5
Phoenix 5
Portsmouth 5
Ribeirão Preto 5
San Francisco 5
Sydney 5
Cagliari 4
Detroit 4
Genoa 4
Hải Dương 4
Jacksonville 4
Johannesburg 4
Las Vegas 4
Lima 4
Manchester 4
Quito 4
Redondo Beach 4
Tashkent 4
Vancouver 4
Wroclaw 4
Amman 3
Asunción 3
Aurora 3
Austin 3
Baghdad 3
Baku 3
Bari 3
Birmingham 3
Brooklyn 3
Calgary 3
Campinas 3
Casalnuovo di Napoli 3
Catania 3
City of London 3
Dayton 3
Guatemala City 3
Guayaquil 3
Istanbul 3
Kingston 3
Kuala Lumpur 3
Totale 2.502
Nome #
Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women 132
Expanded screening for Fabry disease in patients with chronic kidney disease not on dialysis: a multicenter Italian experience 111
miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population 108
Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients 106
Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease 103
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 89
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 84
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 84
A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report 84
The Identification of a Novel Pathogenic Variant of the GLA Gene Associated with a Classic Phenotype of Anderson–Fabry Disease: A Clinical and Molecular Study 82
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 78
Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case 77
Pompe disease: pathogenesis, molecular genetics and diagnosis 77
Halloysite Nanotubes and Sepiolite for Health Applications 76
Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis 75
Fabry Disease and Inflammation: Potential Role of p65 iso5, an Isoform of the NF-κB Complex 75
Identification of Novel Mutations in Patients Affected by Gaucher Disease 74
A novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 72
Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion 72
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 70
Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study 70
Novel Pathogenic Variant of Fabry Disease in a Family with Parapelvic Cysts 69
Calnexin is down-regulated in Fabry disease. A possible implication in protein misfolding 67
Nanomaterials: A Review about Halloysite Nanotubes, Properties, and Application in the Biological Field 65
De novo mutation in a male patient with Fabry disease: a case report 64
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease 62
European Biotech week 61
Up-regulation of gamma-enolase in PMC from Fabry patients 59
Fabry disease, a complex pathology not easy to diagnose 59
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 58
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 58
Misdiagnosi di Febbre Mediterranea Familiare in pazienti con Malattia di Anderson-Fabry 57
The Phenotypic Characterization of the Cammalleri Sisters, an Example of Exceptional Longevity 56
Cytokines gene expression in the tunica albuginea in patients with Peyronie's disease. Pilot study with a control group 55
Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression 54
Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease 53
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings 52
Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs. 50
Role of S128R polymorphism of E-selectin in colon metastasis formation 49
High variability of fabry disease manifestations in an extended italian family 48
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders 46
Fabry disease: a proteomic approach 45
Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease 44
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies 43
Proteomic approach in Fabry disease: a case report 43
Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease 42
Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease 42
Mucopolysaccharidosis Type I and α-Mannosidosis—Phenotypically Comparable but Genetically Different: Diagnostic and Therapeutic Considerations 42
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease 41
Alterazioni introniche in soggetti con sintomatologia riconducibile alla malattia di Fabry 41
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 40
Effects of different RAS mutations on colorectal cancer cells 39
Two distinct amplification events of the c-myc locus in a colorectal tumour 39
Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease. 38
Possible relation between genetic recombination and amplification within the c-myc locus in a case of primary colorectal carcinoma 38
Effects of different RAS mutations on colorectal cancer cells 36
Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis 35
Cytokine gene expression in the tunica albuginea of patients with Peyronie's disease. Pilot study with a control group 35
Response to Simsek et al. 34
Intrachromosomal recombination of the c-myc locus leading to gene amplification 32
Ruolo di H-RAS e K-RAS nell'espressione di mucine nel carcinoma colorettale 32
Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis 32
Ruolo di H-RAS e K-RAS nell'espressione di mucine nel carcinoma colorettale 31
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema. 31
Il polimorfismo S128R dell'E-Selectina: analisi genotipica e caratterizzazione funzionale nell'interazione cellula tumorale-endotelio 31
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach 31
Due differenti meccanismi molecolari coinvolti nel fenomeno dell'amplificazione genica in un caso di carcinoma colorettale 30
Effects of Parietaria judaica pollen on human lung microvascular endothelial cells 30
Antiproteinuric effect of add-on paricalcitol in Fabry disease patients: a prospective observational study. 29
Analysis of cellular signalling and proteomic profiling in Imatinib-resistant chronic myeloid leucemia cells following treatment with carboxyamidotriazole 29
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 28
Role of S128R polymorphism of E-selectin in colon metastasis formation 28
Identificazione ed analisi di complessi proteici nei sieri di pazienti affetti da sclerosi multipla 27
Amplificazione e riarrangiamento nei tumori colorettali 27
Role of H-RAS and K-RAS oncogenes on mucin expression in colorectal carcinoma 27
Studio degli effetti di Imatinib mesilato e CAI su linee cellulari di leucemia mieloide cronica resistenti all'Imatinib mesilato 27
Effetti dell'estratto proteico del polline di Parietaria judaica su cellule endoteliali della microvascolatura polmonare 27
Amplificazione e riarrangiamento nei tumori colorettali 26
Effects of different RAS mutations on colorectal cancer cells 26
Analisi del profilo dell'espressione genica delle cellule di carcinoma del colon umano T84 e T84SF: ruolo del pathway di AKT nel processo metastatico 26
Role of E-selectin in the modulation of metastatic phenotype 26
Identification of a novel mutation in patients with hereditary angioedema 25
New p65 iso5 isoforms as dexamethasone-binding proteins: novel potential therapeutic targets for inflammatory diseases 25
Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia 25
Espressione di geni muc in cellule epiteliali umane normali e tumorali 25
Effetti sinergici dell'azione antitumorale dell'epigallocatechina-3-gallato in combinazione con il carbossiamido-triazolo, un inibitore dei canali del calcio voltaggio-indipendenti 24
Modulation of the MUC1 and MUC2 promoter activity by RAS isoforms 23
Overcoming Imatinib resistance using CAI, a calcium-mediated signal transduction inhibitor: a new therapeutic strategy for chronic myelogenous leukaemia 22
Characterization of transfected HT-29 cells expressing the oncogenic Ras isoform K-rasG13D 20
Family studies in Gaucher Disease: a key resource for early diagnosis and personalized treatment strategies 17
Fabry Disease: Integrating Molecular Pathophysiology, Precision Diagnosis, and Artificial Intelligence Toward Precision Medicine 13
The NF-κB Isoform p65 iso5 Is Associated with Distinct Transcriptional Programs and Signaling Pathways 12
Epigenetic modulation of the gut-muscle axis in pompe disease: Microbiota fingerprints to cellular and molecular pathomechanisms 11
Totale 4.533
Categoria #
all - tutte 14.877
article - articoli 11.314
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202419 0 0 0 0 0 0 0 0 6 0 12 1
2024/20251.572 71 8 93 38 381 55 4 116 95 106 330 275
2025/20262.400 106 171 188 346 431 108 300 97 123 224 211 95
2026/2027542 147 91 304 0 0 0 0 0 0 0 0 0
Totale 4.533